German Chronic Kidney Disease Study

• Conditions: N19; N00-N08; N10-N16; N17-N19; N20-N23; N25-N29; N30-N39; Unspecified kidney failure; Glomerular diseases; Renal tubulo-interstitial diseases

• Registration Number: DRKS00003971
• Lead Sponsor: Medizinische Klinik 4 (Nephrologie und Hypertensiologie),

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-05-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 5200

Inclusion Criteria

eGFR:30-60 ml/min/1,73 m²
OR:
eGFR >60 ml/min/1,73 m²
AND: Proteinuria
(Albuminuria > 300 mg/Tag
OR: total protein > 500 mg/Tag)

Exclusion Criteria

non caucasian origin, solid organ transplantation, active malignancy within 2 years prior to inclusion, heart insufficiency NYHA IV, unable to provide informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
all cause mortality,<br>myocardial infarction,<br>end stage renal disease,<br>halfing of eGFR

Secondary Outcome Measures

Name	Time	Method
Stroke,<br>Procedure of revascularisation in PAD,<br>Hospitalization